Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis. Don’t miss your chance to: -Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies -Learn how to recognize key clinical features that inform the differential diagnosis -Discover strategies to optimize outcomes and quality of life for your young patients This activity is expiring soon—listen now to stay current and earn credit before it’s gone! Click here to claim your CME/NCPD credit: https://bit.ly/4nGZhBG

Christoph U. Correll, MD, Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at Hofstra/Northwell and Chair of Child and Adolescent Psychiatry at Charité University in Berlin, is currently chairing i3 Health’s four-part educational activity, Schizophrenia Update: Navigating the Latest in Research and Treatment. In this interview, he shares recent updates in schizophrenia research and explains why education is so critical for clinicians to optimize their patients’ outcomes. Click here to listen to the full activity podcasts!  Module 1: https://bit.ly/3JsEYKf Module 2: https://bit.ly/436dYa5 Module 3: https://bit.ly/47fkz4p Module 4: https://bit.ly/4oflWWZ

Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, and crucial diagnostic updates. Learn how to shorten diagnosis times and improve long-term patient quality of life. Stay tuned after the interview to hear Module 2 of the podcast series, "Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies" Don't forget to claim your credit after the episode! Click on the link to claim your credit for module 2: bit.ly/43VoFNP

Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, and crucial diagnostic updates. Learn how to shorten diagnosis times and improve long-term patient quality of life. Stay tuned after the interview to hear Module 1 of the podcast series, "Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies" Don't forget to claim your credit after the episode! Click on the link to claim your credit for module 1: bit.ly/3Y3ivHM Click here to continue listening to Module 2 of this podcast series: bit.ly/43VoFNP

Psoriatic arthritis care is rapidly evolving, demanding multidisciplinary collaboration and timely access to evidence-based therapies for optimal patient outcomes. i3 Health's Multidisciplinary Task Force—Increasing Early Intervention and Optimizing Management in Psoriatic Arthritis—convened expert clinicians and a patient moderator to address real-world challenges in screening, diagnosis, comorbidity management, and therapeutic optimization. In this follow-up interview, Archie Franklin, MBA, a psoriatic arthritis patient and Task Force moderator, shares insights on the discussion, the changing treatment landscape, and practical guidance for elevating standards of care. Click here to view the Task Force and claim your CE credit: https://bit.ly/4h5NSKb

Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies. 🎧 Listen now and click the link to claim your CE credit! Claim your credit here: https://bit.ly/4pGrLO5 🔗 Learn more and access continuing education activities: https://i3health.com 📲 Stay connected with i3 Health: Twitter/X: https://bit.ly/42VAYs1 LinkedIn: https://bit.ly/3IMiCmv Facebook: https://bit.ly/46JrQI2 YouTube: https://bit.ly/4pNhWxR Instagram: https://bit.ly/4nUSNzE Threads: https://bit.ly/3Wd6oq9 🎧 Subscribe to the i3 Health Podcast on your favorite streaming platform so you never miss the latest expert discussions!

Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive tumors that present unique diagnostic and treatment challenges. In this accredited activity podcast, leading experts Dr. Andrew E. Hendifar and Dr. Danielle Hutchings from Cedars-Sinai Medical Center share practical strategies and emerging evidence on diagnosis, current therapies, and novel treatment targets. Listen now to gain actionable insights and stay current on evolving approaches in EP-NECs! Click the link to claim your CE credit: https://bit.ly/488fPhK

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care Module 2 by i3 Health

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care - Module 1 by i3 Health

Genetic testing and counseling are crucial components of precision medicine in cancer care, enabling clinicians to deliver the right care, to the right patient, at the right time. i3 Health’s educational activity, Pathways to Precision: Integrating Genetic Counseling and Testing Into Cancer Care, provides a comprehensive foundation for incorporating these tools into practice. In this follow-up interview to the activity, co-chairs Dr. Filipa Lynce, Director of the Inflammatory Breast Cancer at Harvard Medical School, and Catherine Skefos, Certified Genetic Counselor at MD Anderson Cancer Center, share advances that have occurred in the field since the activity was recorded, including clinical trial updates and novel insights for clinicians. Click here to complete the free CME/NCPD/CE activity: https://bit.ly/3HqXjpX

i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives deep into the evolving role of HER2 in non–small cell lung cancer (NSCLC). In a special interview, Dr. Julia Kathleen Rotow—Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School—shares the latest breakthroughs in treating HER2-mutated NSCLC. She highlights why ongoing medical education is crucial in this fast-changing field and offers her insights on where HER2-targeted therapies are headed next. Stay tuned after the interview to listen to Module 1 of this accredited activity! Click below to complete the claim your CE credit: Module 2: bit.ly/405xEJO Click below to complete the Module 1 from this series, HER2 in NSCLC: Actionable Insights and Testing Recommendations Module 1: bit.ly/49NCaQu

i3 Health recently launched an exciting new online educational activity, “What’s New with HER2: Charting New Paths in NSCLC Care.” This two-part series dives deep into the evolving role of HER2 in non–small cell lung cancer (NSCLC). In a special interview, Dr. Julia Kathleen Rotow—Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School—shares the latest breakthroughs in treating HER2-mutated NSCLC. She highlights why ongoing medical education is crucial in this fast-changing field and offers her insights on where HER2-targeted therapies are headed next. Stay tuned after the interview to listen to Module 1 of this accredited activity! Click below to complete the claim your CE credit: Module 1: bit.ly/49NCaQu Click below to complete the next Module in this series, Current and Emerging Treatments for HER2-Mutated NSCLC Module 2: bit.ly/405xEJO

For patients with ulcerative colitis, newly developed therapies and tailored treatment strategies have allowed for a more personalized approach to achieving disease control and remission. In this special podcast interview, Dr. Benjamin Cohen, Co-Section Head and Clinical Director of Inflammatory Bowel Diseases at the Cleveland Clinic, offers a behind-the-scenes look at i3 Health’s Virtual Escape Room, which follows Shawn, a 32-year-old man living with ulcerative colitis. Dr. Cohen discusses the greatest challenges in diagnosis and treatment, the importance of staying current with novel therapies and biomarkers, and how this engaging, gamified format not only enhances learning but also translates to improved patient outcomes. Click here to complete the escape room and claim free CME credit! https://i3Health.com/uc-escape

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Waqas Haque, a Hematology/Oncology Fellow at the University of Chicago, recently shared his perspectives on i3 Health’s CME activity, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With MCED testing moving from research to real-world practice, Dr. Haque discussed the science, challenges, and future of these innovative tests, as well as the importance of staying up to date on emerging advances with continuing education. Click the links below for the full CME activity! Module 1: bit.ly/3X8apxa Module 2 : bit.ly/41rS14I Module 3: bit.ly/4b9JU00 And view the slide decks here: Module 1: bit.ly/4l0NTzc Module 2: bit.ly/4fdXwti Module 3: bit.ly/40AkmoP

As research in dedifferentiated liposarcoma (DDLPS) continues to advance, the importance of multidisciplinary collaboration and access to innovative therapies remains at the forefront of patient care. Recently, Dr. Richard Riedel of Duke Cancer Institute and Dr. Candace Haddox of Dana-Farber Cancer Institute co-chaired i3 Health’s DDLPS Task Force activity, which brought together a panel of experts to address the complexities of this rare and challenging sarcoma subtype. With new clinical trials underway and a growing understanding of the disease’s molecular landscape, Dr. Riedel and Dr. Haddox sat down to highlight promising research directions and insights in honor of Sarcoma Awareness Month in July. After listening to the interview, stay tuned to hear the full accredited podcast with Dr. Riedel and Dr. Haddox, and click the link below to claim free CME/AAPA credit. Click the links below for the Task Force activity! - Accredited CME/AAPA Podcast: https://i3health.com/course-information/podcast-ddlps - Position Statement Published in Cancer Treatment Reviews: https://www.cancertreatmentreviews.com/article/S0305-7372(24)00175-0/fulltext - Live Task Force Recording: https://youtu.be/Otr5_tiFQ68

Join i3 Health for a special live webinar, Increasing Detection and Improving Outcomes in Hereditary Transthyretin Amyloid Cardiomyopathy, being held on Wednesday, July 30 at 5:00 pm ET. In this exclusive event, Dr. Mathew Maurer, the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, will share his expertise and latest insights in the treatment of hereditary ATTR-CM. In this interview, Dr. Maurer shares a preview of the topics he is excited to highlight during the webinar, including signs and symptoms to aid in early diagnosis, advances in genetic testing and new diagnostic modalities, novel therapies that are improving outcomes, and the role of interdisciplinary collaboration. Don’t miss this opportunity to learn from one of the leading voices in hereditary ATTR-CM care. Register at the link below or scan the QR code in the video to secure your spot. We look forward to seeing you! Register Here: https://bit.ly/3UgV7nF

Join i3 Health for a special live webinar, Optimizing Neuroendocrine Tumor Outcomes: Closing the Gaps in Diagnosis and Care, being held on Thursday, July 17th at 12:00 pm Eastern and on Tuesday, August 5th at 3:00 pm Eastern. In this exclusive event, Dr. Aman Chauhan, Leader of the Neuroendocrine Tumor Program at the University of Miami, Sylvester Comprehensive Cancer Center, will share his expertise and latest insights in the treatment of NETs. In this interview, Dr. Chauhan shares a preview of the topics he is excited to highlight during the webinar, including the recent advances which are transforming patient care, the emerging field of theranostics, the evolving role of multidisciplinary care, and practical tips for effective team collaboration. Don’t miss this opportunity to learn from one of the leading voices in NETs care. Register at the link below or scan the QR code in the video to secure your spot. We look forward to seeing you! Register Here! July 17, 2025 @ 12:00 PM ET: https://us02web.zoom.us/webinar/register/WN_2VJ0PmYISae4gAh2KxNlnQ#/registration August 5, 2025 @ 3:00 PM ET: https://us02web.zoom.us/webinar/register/WN_teUE5QgyQJ6sYaLRrkNp9g#/registration

Biliary tract cancer (BTC) presents a complex puzzle for the interprofessional healthcare team. With its diverse subtypes and unique molecular features, diagnosis and treatment require a personalized approach. Stay ahead of the curve with insights from leading experts, Dr. Anjana Pillai and Dr. Rachna Shroff, as they explore the latest genomic research, targeted therapies, and emerging treatment strategies in this dynamic podcast. Listen now to hear the Multidisciplinary Task Force perspective and strategies to optimize patient care in this rapidly evolving landscape. Click here to claim credit for this podcast:

Join us for a special live webinar, Slowing Disease Progression and Optimizing Quality of Life for Patients With ALS, on Wednesday, June 11th at 1:00 pm Eastern. In this exclusive event, Dr. Richard S. Bedlack will share his expertise and latest insights on ALS care. In this preview interview, Dr. Bedlack discusses his unique approach to supporting patients, including his innovative "Stitching Strength" philosophy, and highlights new research on hope-boosting instruments for people living with ALS. He also offers a glimpse into the key topics and messages he’ll be covering during the webinar, all aimed at helping clinicians and caregivers slow disease progression and enhance quality of life for their patients. Don’t miss this opportunity to learn from one of the leading voices in ALS care. Register at the link below or scan the QR code in the video to secure your spot. We look forward to seeing you on June 11th! Click here to register now: https://bit.ly/3Zjb8wm

In this concluding module, Michael A. Davies, MD, PhD, University of Texas, MD Anderson Cancer Center, addresses the critical challenges of managing treatment-associated toxicities in the era of advanced melanoma therapies. Discover practical strategies for handling immune-related adverse events, implementing comprehensive supportive care, and optimizing patient education. This podcast is critical for oncology professionals seeking to balance therapeutic efficacy with quality of life for patients receiving cutting-edge immunotherapy and targeted treatments. Click here to go back and listen to module 1 of this podcast series: bit.ly/4iYmYD2 Click here to claim your CME/NCPD credit: bit.ly/44yO9RB